News

Filter

Current filters:

avanafil

Sanofi to produce avanafil for Vivus

02-08-2013

US drugmaker Vivus (Nasdaq: VVUS) says it has entered into a commercial supply agreement with French…

avanafilMen's HealthPharmaceuticalProductionSanofiSpedraVivus

Vivus partners with Menarini for European and Australia/NZ marketing of ED drug

09-07-2013

US drugmaker Vivus (Nasdaq: VVUS) has entered into a license and commercialization agreement and a supply…

Asia-PacificavanafilEuropeLicensingMarkets & MarketingMen's HealthMenariniPharmaceuticalReproductiveSpedraVivus

European approval for Vivus' ED drug Spedra

27-06-2013

The European Commission yesterday (June 26) has granted marketing authorization for USA-based Vivus'…

avanafilEuropeMen's HealthPharmaceuticalRegulationReproductiveSpedraVivus

US FDA clears new ED drug Stendra

30-04-2012

The US Food and Drug Administration late Friday gave its approval for drug developer Vivus (Nasdaq: VVUS)…

avanafilMen's HealthNorth AmericaPharmaceuticalRegulationReproductiveStendraVivus

Astellas files for EU approval of EC905, EMA accepts avanafil filing

28-03-2012

The European subsidiary of Japanese drug major Astellas Pharma (Tokyo: 4503) has announced the submission…

Astellas PharmaavanafilEuropeMen's HealthPharmaceuticalRegulationVivus

US NDA filings for Vivus’ ED drug avanafil and Corcept’s Corlux for Cushing’s

01-07-2011

California, USA-based Vivus (Nasdaq: VVUS) has submitted a New Drug Application has to the Food and Drug…

avanafilCorluxNorth AmericaPharmaceuticalRare diseasesRegulationReproductiveVivus

Positive Ph III results for VIVUS’ avanafil in diabetics with erectile dysfunction

08-06-2010

California, USA-based VIVUS announced positive results from the Phase III REVIVE-Diabetes (TA-302) study,…

avanafilDiabetesPharmaceuticalReproductiveResearchVivus

COMPANY SPOTLIGHT

Menarini

Back to top